Q fever: Clinical manifestations and treatment

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 5, 2010, Pages 529-539

  Gikas, Achilleas ^a   Kokkini, Sofia ^a   Tsioutis, Constantinos ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Clinical manifestations; Coxiella burnetii infection; Epidemiology; Q fever; Treatment

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE; OFLOXACIN; Q FEVER VACCINE; Q VAX; RIFAMPICIN; UNCLASSIFIED DRUG;

ACUTE DISEASE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CHRONIC HEPATITIS; CHRONICITY; CLINICAL FEATURE; COXIELLA BURNETII; DIAGNOSTIC APPROACH ROUTE; DISEASE TRANSMISSION; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INCIDENCE; LABORATORY TEST; MORBIDITY; MORTALITY; MYOCARDITIS; NEUROLOGIC DISEASE; OSTEOMYELITIS; PERICARDITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANCY; Q FEVER; REVIEW; SEROLOGY; VASCULAR DISEASE;

ADOLESCENT; ANIMALS; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COXIELLA BURNETII; DOXYCYCLINE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; Q FEVER; ZOONOSES;

EID: 77952252996     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.29     Document Type: Review

References (100)

1. Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Q fever: a biological weapon in your backyard. Lancet Infect. Dis. 3(11), 709-721 (2003).
2. Maurin M, Raoult D. Q fever. Clin. Microbiol. Rev. 12(4), 518-553 (1999).
3. Parker NR, Barralet JH, Bell AM. Q fever. Lancet 367, 679-688 (2006).
4. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q fever during pregnancy: a cause of poor fetal and maternal outcome. Ann. NY Acad. Sci. 1166, 79-89 (2009).
5. Raoult D, Stein A. Q fever during pregnancy - a risk for women, fetuses, and obstetricians. N. Engl. J. Med. 330 (5), 371 (1994).
6. Landais C, Fenollar F, Thuny F, Raoult D. From acute Q fever to endocarditis: serological follow-up strategy. Clin. Infect. Dis. 44(10), 1337-1340 (2007).
7. Stein A, Saunders NA, Taylor AG, Raoult D. Phylogenic homogeneity of Coxiella burnetii strains as determined by 16S ribosomal RNA sequencing. FEMS Microbiol. Lett. 113, 339-344 (1993).
8. Seshadri R, Paulsen IT, Eisen JA et al. Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc. Natl Acad. Sci. USA 100, 5455-5460 (2003).
9. Samuel JE, Frazier ME, Mallavia LP. Comparison of Coxiella burnetii plasmids to homologus sequences present in a plasmidless endocarditis causing isolate. Ann. NY Acad. Sci. 590, 33-38 (1990).
10. McCaul TF, Banerjee-Bhatnagar N, Williams JC. Antigenic differences between Coxiella burnetii cells revealed by postembedding immunoelectron microscopy and immunoblotting. Infect. Immun. 59, 3243-3253 (1991).
11. McCaul TF. The developmental cycle of Coxiella burnetii. In: Q fever: The Biology of Coxiella burnetii. Williams JC, Thompson HA (Eds). CRC Press, Boca Raton, FL, USA, 223-258 (1991).
12. Heinzen RA, Hackstadt T, Samuel JE. Developmental biology of Coxiella burnetii. Trends Microbiol. 7, 149-154 (1999).
13. Ghigo E, Pretat L, Desnues B, Capo C, Raoult D, Mege JL. Intracellular life of Coxiella burnetii in macrophages. Ann. NY Acad. Sci. 1166, 55-66 (2009).
14. Raoult D, Marrie T. Q fever. Clin. Infect. Dis. 20, 489-496 (1995).
15. Hilbink F, Penrose M, Kovacova E, Kazar J. Q fever is absent from New Zealand. Int. J. Epidemiol. 22, 945-949 (1993).
16. Palmer SR, Young SE. Q fever endocarditis in England and Wales, 1975-1981. Lancet 25(2), 1148-1149 (1982).
17. Waldhalm DG, Stoenner HG, Simmons RE, Thomas LA. Abortion associated with Coxiella burnetii infection in dairy goats. J. Am. Vet. Med. Assoc. 137, 1580-1581 (1978).
18. Ho T, Htwe KK, Yamasaki N et al. Isolation of Coxiella burnetii from dairy cattle and ticks, and some characteristics of the isolates in Japan. Microbiol. Immunol. 39, 663-671 (1995).
19. Schmeer N, Muller P, Langel J, Krauss H, Frost JW, Wieda J. Q fever vaccines for animals. Zentbl. Bakteriol. Microbiol. Hyg. Ser. A. 267(1), 79-88 (1987).
20. Hornibrook JW, Nelson KR. An institutional outbreak of pneumonitis. I. Epidemiologic and clinical studies. Public Health Rep. 55, 1936-1954 (1940).
21. Tigertt WD, Benenson AS, Gochenour WS. Airborne Q fever. Bacteriol. Rev. 25, 285-293 (1961).
22. Centers for Diseases Control (CDC). Q fever outbreak - Switzerland. MMWR Morb. Mortal. Wkly Rep. 33 (25), 355-356, 361 (1984).
23. Pantanowitz L, Telford SR, Cannon ME. Tick-borne diseases in transfusion medicine. Transfus. Med. 12 (2), 85-106 (2002).
24. Kanfer E, Farrag N, Price C, MacDonald D, Coleman J, Barrett A. Q fever following bone marrow transplantation. Bone Marrow Transplant. 3, 165-166 (1988).
25. Milazzo A, Hall R, Storm PA, Harris RJ, Winslow W, Marmion BP. Sexually transmitted Q fever. Clin. Infect. Dis. 33(3), 399-402 (2001).
26. Kruszewska D, Lembowicz K, Tylewska- Wierbanowska S. Possible sexual transmission of Q fever among humans. Clin. Infect. Dis. 22, 1087-1088 (1996).
27. Beaman MH, Hung J. Pericarditis associated with tick-borne Q fever. Aust. NZ J. Med. 19, 254-256 (1989).
28. Eklund CM, Parker RR, Lackman DB. A case of Q fever probably contracted by exposure to ticks in nature. Public Health Rep. 62, 1413-1416 (1947).
29. Raoult D, Tissot-Dupont H, Foucault C et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine 79(2), 109-123 (2000).
30. Maltezou HC, Raoult D. Q fever in children. Lancet Infect. Dis. 2, 686-691 (2002).
31. Dupuis G, Vouilloz M, Peter O, Mottiez MC. Incidence of Q fever in Valais. Rev. Med. Suisse. Romande. 105, 949-954 (1985).
32. Maltezou HC, Constantopoulou I, Kallergi C et al. Q fever in children in Greece. Am. J. Trop. Med. Hyg. 70 (5), 540-544 (2004).
33. Raoult D, Marrie T, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infect. Dis. 5, 219-226 (2005).
34. Brouqui P, Dupont HT, Drancourt M et al. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch. Intern. Med. 153(5), 642-648 (1993).
35. Glazunova O, Roux V, Freylikman O et al. Coxiella burnetii genotyping. Emerg. Infect. Dis. 11(8), 1211-1217 (2005).
36. Tissot-Dupont H, Raoult D. Clinical aspects, diagnosis and treatment of Q fever. In: Rickettsial Diseases. Raoult D, Parola P (Eds). Informa Healthcare, UK, 291-301 (2007).
37. Tellez A, Sainz C, Echevarria C et al. Q fever in Spain: acute and chronic cases, 1981-1985. Rev. Infect. Dis. 10(1), 198-202 (1988).
38. Tselentis Y, Gikas A, Kofteridis D et al. Q fever in the Greek Island of Crete: epidemiologic, clinical, and therapeutic data from 98 cases. Clin. Infect. Dis. 20(5), 1311-1316 (1995).
39. Takahashi H, Tokue Y, Kikuchi T et al. Prevalence of community-acquired respiratory tract infections associated with Q fever in Japan. Diagn. Microbiol. Infect. Dis. 48, 247-252 (2004).
40. Santoro D, Giura R, Colombo MC et al. Q fever in Como, northern Italy. Emerg. Infect. Dis. 10, 159-160 (2004).
41. Porten K, Rissland J, Tigges A et al. A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany. BMC Infect. Dis. 6, 147 (2006).
42. Schimmer B, Dijkstra F, Vellema P et al. Sustained intensive transmission of Q fever in the south of the Netherlands, 2009. Euro Surveill. 14(19), pii = 19210 (2009).
43. de Alarcon A, Villanueva JL, Viciana P et al. Q fever: epidemiology, clinical features and prognosis. A study from 1983 to 1999 in the South of Spain. J. Infect. 47(2), 110-116 (2003).
44. Arricau-Bouvery N, Rodolakis A. Is Q fever an emerging or re-emerging zoonosis? Vet. Res. 36, 327-349 (2005).
45. Marrie TJ. Epidemiology of Q fever. In: Q fever (Volume I). Marrie TJ (Ed.). CRC Press, Boca Raton, FL, USA, 49-70 (1990).
46. Spelman DW. Q fever: a study of 111 consecutive cases. Med. J. Aust. 1, 547-553 (1982).
47. Vazquez-Lopez F, Rippe ML, Soler T, Rodriguez A, Arribas JM, Perez-Oliva N. Erythema nodosum and acute Q fever: report of a case with granulomatous hepatitis and immunological abnormalities. Acta. Derm. Venereol. 77, 73-74 (1997).
48. Boele van Hensbroek MB, de Vries E, Dolan G, Schneeberger P. Rash and petechiae as presenting signs of Q fever. Pediatr. Infect. Dis. J. 19(4), 358 (2000).
49. Korman TM, Spelman DW, Perry GJ, Dowling JP. Acute glomerulonephritis associated with acute Q fever: case report and review of the renal complications of Coxiella burnetii infection. Clin. Infect. Dis. 26(2), 359-364 (1998).
50. Gikas A, Kofteridis D, Bouros D, Voloudaki A, Tselentis Y, Tsaparas N. Q fever pneumonia: appearance on chest radiographs. Radiology 210(2), 339-343 (1999).
51. Voloudaki AE, Kofteridis DP, Tritou IN, Gourtsoyiannis NC, Tselentis YJ, Gikas AI. Q fever pneumonia: CT findings. Radiology 215(3), 880-883 (2000).
52. Millar JK. The chest film findings in 'Q' fever-a series of 35 cases. Clin. Radiol. 29, 371-375 (1978).
53. Gordon JD, MacKeen AD, Marrie TJ, Fraser DB. The radiographic features of epidemic and sporadic Q fever pneumonia. J. Can. Assoc. Radiol. 35, 293-296 (1984).
54. Marrie TJ. Coxiella burnetii (Q fever) pneumonia. Clin. Infect. Dis. 21(Suppl. 3), 5253-5264 (1995).
55. Derrick EH. The course of infection with Coxiella burnetii. Med. J. Aust. 1, 1051-1057 (1973).
56. Berkovitch M, Aladjem M, Beer S, Cohar K. A fatal case of Q fever hepatitis in a child. Helv. Paediatr. Acta. 40(1), 87-91 (1985).
57. Marrie TJ. Liver involvement in acute Q fever. Chest 94, 896 (1988).
58. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J. Clin. Microbiol. 36(7), 1823-1824 (1998).
59. Marrie TJ. Pneumonia and meningoencephalitis due to Coxiella burnetii. J. Infect. 11(1), 59-61 (1985).
60. Chevalier P, Vandenesch F, Brouqui P et al. Fulminant myocardial failure in a previously healthy young man. Circulation 95, 1654-1657 (1997).
61. Powell O. 'Q' fever: clinical features in 72 cases. Aust. Ann. Med. 9, 214-223 (1960).
62. Sheridan P, MacCaig JN, Hart RJ. Myocarditis complicating Q fever. Br. Med. J. 2(5911), 155-156 (1974).
63. Camacho MT, Outschoorn I, Tellez A, Sequí J. Autoantibody profiles in the sera of patients with Q fever: characterization of antigens by immunofluorescence, immunoblot and sequence analysis. J. Autoimmune Dis. 2, 10 (2005).
64. Landais C, Fenollar F, Constantin A et al. Q fever osteoarticular infection: four new cases and a review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 26(5), 341-347 (2007).
65. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin. Infect. Dis. 33(3), 312-316 (2001).
66. Fenollar F, Thuny F, Xeridat B, Lepidi H, Raoult D. Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin. Infect. Dis. 42(6), 818-821 (2006).
67. Stein A, Raoult D. Q fever endocarditis. Eur. Heart J. 16(Suppl. B), 19-23 (1995).
68. Houpikian P, Habib G, Mesana T, Raoult D. Changing clinical presentation of Q fever endocarditis. Clin. Infect. Dis. 34(5), E28-E31 (2002).
69. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification of the diagnostic criteria proposed by the Duke endocarditis service to permit improved diagnosis of Q fever endocarditis. Am. J. Med. 100(6), 629-633 (1996).
70. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30, 633-638 (2000).
71. Yebra M, Marazuela M, Albarran F, Moreno A. Chronic Q fever hepatitis. Rev. Infect. Dis. 10(6), 1229-1230 (1988).
72. Botelho-Nevers E, Fournier PE, Richet H et al. Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur. J. Clin. Microbiol. Infect. Dis. 26(9), 635-640 (2007).
73. Marmion BP, Shannon M, Maddocks I, Storm P, Pentilla I. Protracted fatigue and debility after acute Q fever. Lancet 347, 978-979 (1996).
74. Ayres JG, Flint N, Smith EG et al. Post-infection fatigue syndrome following Q fever. Q. J. Med. 91(2), 105-123 (1998).
75. Stein A, Raoult D. Q fever during pregnancy: a public health problem in Southern France. Clin. Infect. Dis. 27(3), 592-596 (1998).
76. Syrucek L, Sobeslavsky O, Gutvirth I. Isolation of Coxiella burnetii from human placentas. J. Hyg. Epidemiol. Microbiol. Immunol. 2, 29-35 (1958).
77. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin. Infect. Dis. 45, 548-555 (2007).
78. Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch. Intern. Med. 162(6), 701-704 (2002).
79. Vaidya VM, Malik SV, Kaur S, Kumar S, Barbuddhe SB. Comparison of PCR, immunofluorescence assay, and pathogen isolation for diagnosis of Q fever in humans with spontaneous abortions. J. Clin. Microbiol. 46(6), 2038-2044 (2008).
80. Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin. Infect. Dis. 44(2), 232-237 (2007).
81. Raoult D, Houpikian P, Tissot-Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of two regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Intern. Med. 159(2), 167-173 (1999).
82. Siegman-Igra Y, Kaufman O, Keysary A, Rzotkiewicz S, Shalit I. Q fever endocarditis in Israel and a worldwide review. Scand. J. Infect. Dis. 29(1), 41-49 (1997).
83. Fournier PE, Marrie TJ, Raoult D. Diagnosis of Q fever. J. Clin. Microbiol. 36(7), 1823-1834 (1998).
84. Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin. Diagn. Lab. Immunol. 1(2), 189-196 (1994).
85. Raoult D, Vestris G, Enea M. Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of strains in HEL cells. J. Clin. Microbiol. 28(11), 2482-2484 (1990).
86. Fournier PE, Raoult D. Comparison of PCR and serology assays for early diagnosis of acute Q fever. J. Clin. Microbiol. 41(11), 5094-5098 (2003).
87. Fenollar F, Fournier PE, Raoult D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J. Clin. Microbiol. 42(11), 4919-4924 (2004).
88. Drancourt M, Raoult D, Xeridat B, Milandre L, Nesri M, Dano P. Q fever meningoencephalitis in five patients. Eur. J. Epidemiol. 7(2), 134-138 (1991).
89. Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob. Agents Chemother. 45(12), 3644-3646 (2001).
90. Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr. Infect. Dis. J. 17, 429-431 (1998).
91. Abramson JS, Givner LB. Should tetracycline be contraindicated for treatment of presumed Rocky Mountain spotted fever in children less than 9 years of age? Pediatrics 86,123-124 (1990).
92. Levy P, Raoult D, Razongles JJ. Q fever and autoimmunity. Eur. J. Epidemiol. 5(4), 447-453 (1989).
93. Spyridaki I, Psaroulaki A, Vranakis I, Tselentis Y, Gikas A. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics. Antimicrob. Agents Chemother. 53(6), 2690-2692 (2009).
94. Rolain JM, Boulos A, Mallet MN, Raoult D. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Antimicrob. Agents Chemother. 49, 2673-2676 (2005).
95. Marmion BP, Ormsbee RA, Kyrkou M et al. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol. Infect. 104(2), 275-287 (1990).
96. Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med. J. Aust. 160(11), 704-708 (1994).
97. Kazar J, Brezina R, Palanova A, Turda B, Schramek S. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull. World Health Organ. 60(3), 389-394 (1982).
98. Ascher MS, Berman MA, Ruppanner R. Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans. J. Infect. Dis. 148(2), 214-222 (1983).
99. Kazar J, Gajdosova E, Kovacova E, Valkova D. Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains. Acta Virol. 39(5-6), 243-249 (1995).
100. Enserink M. Infectious diseases. Questions abound in Q-fever explosion in the Netherlands. Science 327(5963), 266-267 (2010).